Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the <scp>A</scp>ustralian <scp>IPF R</scp>egistry
Ian Glaspole(Monash University), Tamera J. Corte(The University of Sydney), Yuben Moodley(Monash Health), Sacha Macansh(Lung Foundation Australia), Nicole Goh(Royal Brompton Hospital), Christopher Zappala(Royal Brisbane and Women's Hospital), Eldho Paul(Monash Health), Paul N. Reynolds(Royal Adelaide Hospital), Sally Chapman(Royal Adelaide Hospital), Wendy A. Cooper(The University of Sydney), Annabelle Mahar(The University of Sydney), Samantha Ellis(The Alfred Hospital), Peter Hopkins(The University of Queensland), E. Haydn Walters(University of Tasmania)
Cited by 124
Related Papers
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
|The Lancet Respiratory Medicine|2018|592
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
|European Respiratory Journal|2015|462
Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
|American Journal Of Pathology|2009|361